免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

AVA (增强血管分析)

K号: K201369 · 2020-09-16

决定日期2020-09-16
产品代码LLZ
咨询委员会RA
决定实质等同

器械摘要

AVA (Augmented Vascular Analysis) is the device name listed in this FDA 510(k) record. The listed applicant is See-Mode Technologies Pte, Ltd.. It received FDA 510(k) clearance on 2020-09-16 under 510(k) number K201369. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the AVA (Augmented Vascular Analysis)?

AVA (Augmented Vascular Analysis) is a medical device that received FDA 510(k) clearance on 2020-09-16. The listed applicant is See-Mode Technologies Pte, Ltd.. The 510(k) number is K201369.

When did AVA (Augmented Vascular Analysis) receive FDA 510(k) clearance?

AVA (Augmented Vascular Analysis) received FDA 510(k) clearance on 2020-09-16, under 510(k) number K201369.

Who is the listed applicant for AVA (Augmented Vascular Analysis)?

The FDA 510(k) record lists See-Mode Technologies Pte, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for AVA (Augmented Vascular Analysis)?

The FDA product code for AVA (Augmented Vascular Analysis) is LLZ.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明See-Mode Technologies Pte, Ltd.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:LLZ)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑